On April 1, 2024, Stavros G. Vizirgianakis announced that he desires to engage with management and the board of directors of Apyx Medical Corporation to discuss the numerous issues facing the Company and in the near future and would like to work with management and the board of directors of the Company to conduct a strategic review of all commercial activities and to gain deeper insight into the financial and operational challenges that lie ahead so that any necessary changes and meaningful actions can be implemented to address shareholder concerns, restore confidence and drive value creation.